WaveMan
WaveMan · Company
TDOC · Teladoc Health, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

TDOC Teladoc Health (TDOC) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-offices & clinics of doctors of medicine · CIK 0001477449
Quote by TradingView
Form 144 · 7
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
166
13F, latest reported quarter
Conversions, 180 days
36
Codes C/M, not in net · no price filed

What the filings say about TDOC

Insiders, 180 days
-$990.1K net sold
6 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$455.5K
7 notices

Teladoc Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Teladoc Health, Inc. insiders sold a net $990.1K of stock across 273 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Catapano Joseph Ronald
Chief Accounting Officer
SELL
2026-10-05 SECtraded 2026-10-02
655
$3.7K
+8.1%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Sep 2, 2026.
  • The trade is 4.6% of the 14,293 shares held after it.
  • 4 other insiders sold within 30 days.
  • 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Catapano Joseph Ronald sold about $3.7K of TDOC on Oct 2, 2026; 4 other insiders sold within 30 days and 166 funds added in the latest 13F quarter.
DIVITA CHARLES III
CHIEF EXECUTIVE OFFICER
SELL
2026-09-14 SECtraded 2026-09-11
17,805
$108.7K
-5.2%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Sep 2, 2026.
  • The trade is 3.8% of the 465,535 shares held after it.
  • 4 other insiders sold within 30 days.
  • 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF EXECUTIVE OFFICER DIVITA CHARLES III sold about $108.7K of TDOC on Sep 11, 2026; 4 other insiders sold within 30 days and 166 funds added in the latest 13F quarter.
Nueno Carlos
President, International
SELL
2026-09-03 SECtraded 2026-09-02
6,200
$39.1K
-0.6%
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Jun 2, 2026.
  • The trade is 9.6% of the 64,744 shares held after it.
  • 4 other insiders sold within 30 days.
  • 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, International Nueno Carlos sold about $39.1K of TDOC on Sep 2, 2026; 4 other insiders sold within 30 days and 166 funds added in the latest 13F quarter.
Vandervoort Adam C
CHIEF LEGAL OFFICER, SECRETARY
SELL
2026-09-03 SECtraded 2026-09-02
7,573
$47.7K
-0.6%
Context
  • 22 earlier Form 4 trades (code P or S) here by this insider (22 sales), the last on Jun 2, 2026.
  • The trade is 6.4% of the 117,616 shares held after it.
  • 4 other insiders sold within 30 days.
  • 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF LEGAL OFFICER, SECRETARY Vandervoort Adam C sold about $47.7K of TDOC on Sep 2, 2026; 4 other insiders sold within 30 days and 166 funds added in the latest 13F quarter.
Bliss Kelly
President, U.S. Group Health
SELL
2026-09-03 SECtraded 2026-09-02
7,357
$46.4K
-0.6%
Context
  • 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Jul 6, 2026.
  • The trade is 7.9% of the 92,832 shares held after it.
  • 4 other insiders sold within 30 days.
  • 166 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, U.S. Group Health Bliss Kelly sold about $46.4K of TDOC on Sep 2, 2026; 4 other insiders sold within 30 days and 166 funds added in the latest 13F quarter.
273 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 268 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$990.1K over 180 days
-$362.7K over 90 days
more than 51% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
166 funds bought in last quarter
more than 68% of Healthcare Services
Revenue
-1.5% year over year
below 80% of Healthcare Services
Margin
-7.9% net margin
below 67% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
16.7% of the float short (float per yahoo 2026-10-26) · 8.9 days to cover · settled 2026-09-30
more than 93% of Healthcare Services
What changed in the last 30 days
Oct 5Chief Accounting Officer Catapano Joseph Ronald sold $3.7K (Oct 2)

Watch TDOC

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-25.2%12M
-46%-25%-4%+17%2025-102025-122026-022026-042026-062026-082026-10 2026-03-02 · DIVITA CHARLES III sold $256.7K2026-03-11 · DIVITA CHARLES III sold $152.2K2026-06-02 · DIVITA CHARLES III sold $146.0K2026-03-02 · Vandervoort Adam C sold $138.7K2026-03-02 · Bliss Kelly sold $136.4K2025-12-11 · DIVITA CHARLES III sold $130.8K2026-06-11 · DIVITA CHARLES III sold $125.4K2026-03-03 · Rodrigues Fernando M. sold $124.9K2026-09-02 · DIVITA CHARLES III sold $115.5K2026-09-11 · DIVITA CHARLES III sold $108.7K2026-03-02 · Nueno Carlos sold $103.2K2026-03-02 · Rodrigues Fernando M. sold $83.5K2026-06-03 · Rodrigues Fernando M. sold $70.8K2025-11-14 · Paulus Kenneth H bought $69.4K2026-06-02 · Vandervoort Adam C sold $60.3K2026-06-02 · Bliss Kelly sold $58.6K2026-09-02 · Vandervoort Adam C sold $47.7K2026-06-02 · Nueno Carlos sold $47.3K2026-09-02 · Bliss Kelly sold $46.4K2026-06-02 · Rodrigues Fernando M. sold $43.3K2025-12-02 · Vandervoort Adam C sold $42.8K2026-09-02 · Nueno Carlos sold $39.1K2025-12-02 · Bliss Kelly sold $34.3K2025-12-03 · Rodrigues Fernando M. sold $31.5K2025-12-02 · Nueno Carlos sold $29.2K2026-07-06 · Bliss Kelly sold $23.8K2026-07-01 · Bliss Kelly sold $22.5K2026-06-29 · Bliss Kelly sold $21.2K2025-12-02 · Rodrigues Fernando M. sold $17.4K2026-03-02 · Catapano Joseph Ronald sold $6.8K2026-07-02 · Catapano Joseph Ronald sold $5.9K2026-01-05 · Catapano Joseph Ronald sold $5.4K2026-10-02 · Catapano Joseph Ronald sold $3.7K2026-04-02 · Catapano Joseph Ronald sold $3.4K2026-06-02 · Catapano Joseph Ronald sold $2.2K2026-09-02 · Catapano Joseph Ronald sold $1.7K2026-09-11 · DIVITA CHARLES III filed to sell $108.7K2026-09-03 · Rodrigues Fernando M. filed to sell $63.9K2026-09-02 · Bliss Kelly filed to sell $46.4K2026-09-02 · DIVITA CHARLES III filed to sell $115.5K2026-09-02 · Nueno Carlos filed to sell $39.1K2026-09-02 · Rodrigues Fernando M. filed to sell $34.3K2026-09-02 · Vandervoort Adam C filed to sell $47.7K2026-07-06 · Bliss Kelly filed to sell $23.8K2026-07-01 · Bliss Kelly filed to sell $22.5K2026-06-29 · Bliss Kelly filed to sell $21.2K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns TDOC: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
16,223,134 sh
$137.6M
VANGUARD PORTFOLIO MANAGEMENT LLC
12,685,592 sh
$107.6M
Point72 Asset Management, L.P.
8,239,927 sh
$69.9M
RENAISSANCE TECHNOLOGIES LLC
8,072,842 sh
$68.5M
Voss Capital, LP
8,046,679 sh
$68.2M

Congress trades in TDOC

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

TDOC planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
DIVITA CHARLES III
Filed 2026-09-11
$108.7K
Rodrigues Fernando M.
Filed 2026-09-03
$63.9K
Bliss Kelly
Filed 2026-09-02
$46.4K
DIVITA CHARLES III
Filed 2026-09-02
$115.5K
Nueno Carlos
Filed 2026-09-02
$39.1K

TDOC mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
KraneShares Man Buyout Beta Index ETF
$214.6K position · as of 2026-06-30
1.3%
Global X HealthTech ETF
$295.1K position · as of 2026-05-31
1.2%
PIMCO RAE US Small Fund
$25.5M position · as of 2026-06-30
0.7%
Allspring Small Company Value Portfolio
$4.3M position · as of 2026-07-31
0.6%
Small-Cap Value Fund
$2.1M position · as of 2026-06-30
0.6%
VANGUARD MARKET NEUTRAL FUND
$3.3M position · as of 2026-06-30
0.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $990.1K sold by insiders over 180 days, 166 funds added last quarter, $455.5K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVAAVAHGHADUSSERABDSXBLLN

TDOC financials

Revenue growth
-1.5%
XBRL, annual
Net margin
-7.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.5B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-7.1%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$253.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.00x
long-term 2026-06-30 plus current 2021-12-31 (54 months older than the period end); equity 2026-06-30
Cash flow to debt
n/a
no debt to cover
Return on equity
-13.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-6.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-9.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$359.4M
market value at close 2026-10-26 on 2026-07-23 shares, plus long-term 2026-06-30 plus current 2021-12-31 (54 months older than the period end), minus cash 2026-06-30
FCF yield
+22.4%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$2.5B$2.6B$2.6B$2.4B
Operating income-$263.0M-$1.0B-$248.6M-$13.7B
Net income-$200.3M-$1.0B-$220.4M-$13.7B
EPS (diluted)-1.14-5.87-1.34-84.60
Operating cash flow$294.4M$293.7M$350.0M$189.3M
Cash$781.1M$1.3B$1.1B$918.2M
Long-term debt$994.9M$991.4M$1.5B$1.5B
SEC XBRL, fiscal years, as known on 2026-10-27

TDOC Stock Sonar score 6/7 axes

Find similar shapesCompare

TDOC ranks highest on financial health (99th percentile) and institutional and government (72nd), and lowest on growth (20th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
37
Inputs
  • Return on equity-13.0% · 38 pct, sector of 70
  • Return on assets-6.3% · 41 pct, sector of 88
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-9.7% · 33 pct, sector of 68
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 61
  • Cash flow to debtno debt to cover
Growth
20
Inputs
  • Revenue growth, YoY-1.5% · 20 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
25
Inputs
  • Net Form 4 buying (codes P and S), 180d-$990K · 49 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
72
Inputs
  • Funds adding, latest quarter166 · 68 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$1.4M · 76 pct, universe of 1,063
Risk and compliance
28
Inputs
  • Short interest, % of float+16.7% · 12 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+10.6% · 45 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

TDOC filings, in plain words

Are Teladoc Health insiders buying or selling TDOC?

In the 180 days to 2026-10-27, Teladoc Health insiders were net sellers, a net $990.1K across purchases and sales reported on Form 4, by 6 sellers.

Are there planned insider sales of TDOC?

Yes. 7 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $455.5K of stock; the latest, by DIVITA CHARLES III, was filed 2026-09-11.

Read the full summary

In the 180 days to 2026-10-27, Teladoc Health insiders were net sellers of TDOC, a net $990.1K across purchases and sales reported on Form 4 by 6 sellers. None of the 19 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 7 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $455.5K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies